Encodia
PrivateLast Round
Grant
May 1, 2021
Total Funding Raised
$75.7M
Company Overview
Encodia operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in May 2021.
Encodia is a biotechnology company that develops a next-generation digital proteomics platform utilizing single-molecule protein sequencing for scalable protein analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Encodia Comparables
Compare Encodia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Glyphic Biotechnologies | 87% | |
| Erisyon | 84% | |
| Prisma Biotechnology | 82% |
For institutional investors. Book with your work email.
Encodia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2021 | ||||
| Series C | Jan 27, 2021 | ||||
| Grant | Sep 13, 2018 | ||||
| Grant | Sep 1, 2017 | ||||
| Grant | Sep 1, 2016 |
For institutional investors. Book with your work email.
Encodia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series C |
| National Cancer Institute | Grant |
| GV | Series C |
| NIH RADx | Grant |
| Nan Fung Life Sciences | Series C |
| Northpond Ventures | Series C |
| Biomatics Capital Partners | Series B, Series A, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Monthly visitors increased 75% MoM.
- May 1, 2021
$256K grant received from National Institute of General Medical Sciences.
For institutional investors. Book with your work email.
Encodia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Encodia's valuation, stock price, and market status.
Is Encodia a public or private company?
Encodia is a private company.
What is the current stock price of Encodia?
Encodia is a private company, so its shares have no public market price. Caplight tracks Encodia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Encodia worth (valuation)?
Valuation information for Encodia is not publicly available.
Can I buy Encodia stock?
Encodia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Encodia's last funding round?
Encodia's most recent funding round was Grant on May 1, 2021.
Who are the main investors in Encodia?
Key investors in Encodia include Deerfield Management, National Cancer Institute, Northpond Ventures, Northpond Ventures, National Institute of General Medical Sciences.
Will Encodia IPO soon?
No public IPO plans have been announced for Encodia.
How can I track Encodia secondary market activity?
Caplight tracks bids, offers, and trades in Encodia's shares on secondary markets.